載入...
Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy
Type 2 diabetes mellitus (T2DM) is characterized by multiple metabolic abnormalities and current approaches to treatment involve a stepwise approach, frequently involving the use of combination therapy. The addition of the sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin, to metformin...
Na minha lista:
| 發表在: | Clin Med Insights Endocrinol Diabetes |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043932/ https://ncbi.nlm.nih.gov/pubmed/30013414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551418786258 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|